$45 Million

Aytu BioScience

Buy-side

Exclusive Financial Advisor, December 2020

Aytu BioScience
Merger with Neos Therapeutics, Inc.

Aytu BioScience is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. The company currently markets a portfolio of prescription products addressing large primary care and pediatric markets. Aytu also operates a consumer health subsidiary, Innovus Pharmaceuticals, Inc., a specialty pharmaceutical company commercializing, licensing and developing safe and effective consumer healthcare products designed to improve men's and women's health and vitality. The Innovus product portfolio is commercialized through direct-to-consumer marketing channels utilizing the company's proprietary Beyond Human® marketing and sales platform. Aytu's strategy is to continue building its portfolio of revenue-generating Rx and consumer health products, leveraging its focused commercial team and expertise to build leading brands within large therapeutic markets.

Neos Therapeutics, Inc. is a commercial-stage pharmaceutical company developing and manufacturing central nervous system (CNS)-focused products. Neos markets Adzenys XR-ODT® (amphetamine) extended-release orally disintegrating tablets, Cotempla XR-ODT® (methylphenidate) extended-release orally disintegrating tablets, and Adzenys-ER® (amphetamine) extended-release oral suspension, all for the treatment of ADHD. Neos also has a development candidate, NT0502, for the treatment of sialorrhea in patients with neurological conditions.

More Like This

Apr 2023
$55 Million

Acquisition of all assets related to the REMI Robotic Navigation System from Fusion Robotics, LLC

Exclusive Financial Advisor

View Details >
Apr 2023

Acquisition and Financing of Shapiro Aesthetic Plastic Surgery & Skin Klinic

Exclusive Financial Advisor

View Details >
Nov 2022

Inspire Aesthetics, Inc., a Portfolio Company of Hidden Harbor Capital Partners, Has Acquired McCollough Plastic Surgery Clinic

Exclusive Financial Advisor

View Details >